Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states

被引:267
作者
Gersuk, Geoffrey M.
Underhill, David M.
Zhu, Liqun
Marr, Kieren A.
机构
[1] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98109 USA
[2] Univ Washington, Dept Med, Seattle, WA 98109 USA
[3] Univ Washington, Dept Microbiol, Seattle, WA 98109 USA
[4] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA USA
关键词
D O I
10.4049/jimmunol.176.6.3717
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aspergillus fumigatus is a common cause of invasive and allergic pulmonary disease. Resting conidia of the filamentous fungus are constantly inhaled, but cause infection only after initiating hyphal growth. In this study, we have explored whether macrophages can distinguish between resting spores and the maturing, potentially invasive form of the fungus. Although macrophages bind and ingest A. fumigatus resting conidia efficiently, there is little inflammatory response; NF-kappa beta is not activated, inflammatory cytokines are not induced, and reactive oxygen species are not produced. However, maturing A. fumigatus conidia and germ tubes stimulate NF-kappa beta secretion of proinflammatory cytokines and production of reactive oxygen by human monocyte-derived macrophages and murine macrophages from multiple anatomical sites. These responses are in part mediated by dectin-1, which binds cell wall beta-glucan that is not present on the surface of dormant conidia, but is present after cellular swelling and loss of the hydrophobic proteinaceous cell wall. Dectin-1 binding to germ tubes augments, but is not required for, TLR2-mediated inflammatory cytokine secretion. Dectin-1 recognition of germ tubes also stimulates TNF-alpha production in the absence of both TLR2 and MyD88 signaling. These data demonstrate one mechanism by which the pulmonary inflammatory response is tailored toward metabolically active cells, thereby avoiding unnecessary tissue damage with frequent inhalation of ubiquitous spores.
引用
收藏
页码:3717 / 3724
页数:8
相关论文
共 30 条
  • [11] Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display
    Hohl, Tobias M.
    Van Epps, Heather L.
    Rivera, Amariliz
    Morgan, Laura A.
    Chen, Patrick L.
    Feldmesser, Marta
    Pamer, Eric G.
    [J]. PLOS PATHOGENS, 2005, 1 (03) : 232 - 240
  • [12] Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state
    Hume D.A.
    Underhill D.M.
    Sweet M.J.
    Ozinsky A.O.
    Liew F.Y.
    Aderem A.
    [J]. BMC Immunology, 2 (1)
  • [13] Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages
    Ibrahim-Granet, O
    Philippe, B
    Boleti, H
    Boisvieux-Ulrich, E
    Grenet, D
    Stern, M
    Latgé, JP
    [J]. INFECTION AND IMMUNITY, 2003, 71 (02) : 891 - 903
  • [14] LECTIN-LIKE ATTACHMENT SITES ON MURINE PULMONARY ALVEOLAR MACROPHAGES BIND ASPERGILLUS-FUMIGATUS CONIDIA
    KAN, VL
    BENNETT, JE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) : 407 - 414
  • [15] Aspergillus fumigatus and aspergillosis
    Latgé, JP
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (02) : 310 - +
  • [16] The cyclic AMP-dependent protein kinase A network regulates development and virulence in Aspergillus fumigatus
    Liebmann, B
    Müller, M
    Braun, A
    Brakhage, AA
    [J]. INFECTION AND IMMUNITY, 2004, 72 (09) : 5193 - 5203
  • [17] Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus
    Mambula, SS
    Sau, K
    Henneke, P
    Golenbock, DT
    Levitz, SM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39320 - 39326
  • [18] Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens
    Marr, KA
    Balajee, SA
    Hawn, TR
    Ozinsky, A
    Pham, U
    Akira, S
    Aderem, A
    Liles, WC
    [J]. INFECTION AND IMMUNITY, 2003, 71 (09) : 5280 - 5286
  • [19] Aspergillosis - Pathogenesis, clinical manifestations, and therapy
    Marr, KA
    Patterson, T
    Denning, D
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (04) : 875 - +
  • [20] Mehrad B, 1999, J IMMUNOL, V162, P1633